Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1L1 | Q9UHC9 | 3/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | INPP5D | Q92835 | 1/20 | 0.58 |
| ▸ | SRD5A1 | P18405 | 5/20 | 0.57 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.57 |
| ▸ | FNTA | P49354 | 3/20 | 0.55 |
| ▸ | FNTB | P49356 | 3/20 | 0.55 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.54 |
| ▸ | CDC25A | P30304 | 5/20 | 0.53 |
| ▸ | POLA1 | P09884 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3123616 | 1.00 | NPC1L1 (0.59) | NPC1L1USP2LMNACYP2D6CYP2C19 | |
| SCHEMBL17817528 | 0.89 | CYP2D6 (0.60) | NPC1L1USP2LMNACYP2D6CYP2C19 | |
| SCHEMBL17817529 | 0.89 | CYP2D6 (0.60) | NPC1L1USP2LMNACYP2D6CYP2C19 | |
| SCHEMBL11327438 | 0.88 | CYP2D6 (0.59) | NPC1L1USP2LMNACYP2D6CYP2C19 | |
| SCHEMBL1689231 | 0.88 | NPC1L1 (0.62) | NPC1L1USP2LMNACYP2D6CYP2C19 | |
| SCHEMBL9580414 | 0.83 | FNTA (0.54) | NPC1L1USP2LMNACYP2D6CYP2C19 | |
| Cholestan-3-One SCHEMBL24151938 | 0.82 | GPBAR1 (0.74) | NPC1L1USP2LMNACYP2D6CYP2C19 | |
| Cholestan-3-One SCHEMBL14360529 | 0.82 | GPBAR1 (0.74) | NPC1L1USP2LMNACYP2D6CYP2C19 | |
| SCHEMBL14441614 | 0.82 | CYP2D6 (0.62) | NPC1L1USP2LMNACYP2D6CYP2C19 | |
| Cholestan-3-One SCHEMBL643015 | 0.82 | GPBAR1 (0.74) | NPC1L1USP2LMNACYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9180132-B2 | Antimicrobial cationic steroids and methods of use | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2015-11-10 | — | — | US | disclosed |
| US-9056048-B2 | Synthesis and use of cationic steroids for anti-inflammatory drug therapy | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2015-06-16 | — | — | US | disclosed |
| US-20130137668-A1 | Antimicrobial Cationic Steroids and Methods of Use | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2013-05-30 | — | — | US | disclosed |
| EP-2542245-A1 | ANTIMICROBIAL CATIONIC STEREOIDS AND METHODS OF USE | The Trustees Of The University Of Pennsylvania (US) | 2013-01-09 | — | — | EP | disclosed |
| WO-2011109704-A1 | ANTIMICROBIAL CATIONIC STEREOIDS AND METHODS OF USE | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA CENTER FOR TECHNOLOGY TRANSFER (US) | 2011-09-09 | — | — | WO | disclosed |
| WO-2010062562-A1 | SYNTHESIS AND USE OF CATIONIC STEROIDS FOR ANTI-INFLAMMATORY DRUG THERAPY | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2010-06-03 | — | — | WO | disclosed |
| US-20090124591-A1 | Synthesis and Use of Cationic Steroids for Anti-Inflammatory Drug Therapy | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2009-05-14 | — | — | US | disclosed |
| US-7442386-B2 | Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2008-10-28 | — | — | US | disclosed |
| EP-1424998-A4 | SYNTHESIS AND USE OF REAGENTS FOR IMPROVED DNA LIPOFECTION AND/OR SLOW RELEASE PRODRUG AND DRUG THERAPIES | UNIV PENNSYLVANIA (US) | 2005-11-23 | — | — | EP | disclosed |
| US-20050069577-A1 | Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies | TRUSTEES OF UNIVERSITY OF PENNSYLVANIA | 2005-03-31 | — | — | US | disclosed |
| EP-1424998-A1 | SYNTHESIS AND USE OF REAGENTS FOR IMPROVED DNA LIPOFECTION AND/OR SLOW RELEASE PRODRUG AND DRUG THERAPIES | The Trustees of The University of Pennsylvania (US) | 2004-06-09 | — | — | EP | disclosed |
| WO-2003015757-A1 | SYNTHESIS AND USE OF REAGENTS FOR IMPROVED DNA LIPOFECTION AND/OR SLOW RELEASE PRODRUG AND DRUG THERAPIES | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2003-02-27 | — | — | WO | disclosed |
| US-6274118-B1 | INJECTING PATIENT HAVING ENDOCRINE CANCER IN NON-PROSTATIC TISSUE WITH BIOLOGICAL BINDING UNITS WHICH BIND TO PROSTATE SPECIFIC ANTIGEN PRODUCED BY NON-PROSTATIC TISSUE | NORDION INTERNATIONAL INC. (CA) | 2001-08-14 | — | — | US | disclosed |
| WO-1995002424-A1 | LOCALIZATION AND THERAPY OF NON-PROSTATIC ENDOCRINE CANCER WITH AGENTS DIRECTED AGAINST PROSTATE SPECIFIC ANTIGEN | NORDION INTERNATIONAL INC. (CA) | 1995-01-26 | — | — | WO | disclosed |
| US-4097334-A | Process for the preparation of androstane-3,17-dione derivatives | SCHERING AKTIENGESELLSCHAFT (DT) | 1978-06-27 | — | — | US | disclosed |